nature.com/articles/s4159…

A multidisciplinary research team at the Wyss Institute has developed a new coating technology that holds promise to substantially increase the lifespan of implanted and wearable biosensors while retaining their electrical signaling activities bit.ly/4j7sjZr

In the face of adversity, we at the Wyss Institute won't stop pursuing our mission. We'll support our community, which has devoted itself to saving the lives of others & the planet. To do that, we need your help. Take a stand & show that science matters. wyss.harvard.edu/news/the-impor…

For anyone who cares about their neighbors & the health of their loved ones, let's fight again for freedom. Now, it's not about taxation without representation; it's about science funding cessation without justification. If this resonates, please share. wyss.harvard.edu/news/common-se…

Excited to share our new preprint! It's a light-guided approach for precise and programmable molecular patterning, enabling multiplexed single-molecule force spectroscopy—no lithography needed. Read more at bioRxiv: doi.org/10.1101/2025.0… #Mechanobiology #SingleMolecule

Don Ingber, the @WyssInstitute’s founding director, said a stop-work order targeted two of his organ-on-a-chip projects. He details the rush to hold onto the consequential projects, talented researchers — and system that has driven American innovation. bit.ly/3GJ3nJK

New preprint on single-molecule mechanostructural fingerprinting! doi.org/10.1101/2025.0… We use DNA nanoswitch calipers to characterize the geometry and mechanical stability of telomeric DNA G-quadruplexes. #Biophysics #SingleMolecule #Mechanobiology #DNAnanotech

Self-assembling protein nanoparticles for cytosolic delivery of nucleic acids and proteins go.nature.com/4mxazJw

Outstanding collaborative effort to advance the field of non-viral delivery systems for genome editors, nucleic acid, and protein therapeutics BIDMC Department of Surgery Wyss Institute Harvard Medical School HST Much thanks to David R. Liu and Somatic Cell Genome Editing (SCGE) Outreach consortium! wyss.harvard.edu/news/entering-…

The May issue is live nature.com/nbt/volumes/43… On the cover, a platform for template-independent enzymatic synthesis of RNA oligonucleotides using reversible terminator nucleoside triphosphates that offers a sustainable alternative to traditional methods go.nature.com/3zBfDZf

New paper out, amazing team Wyss Institute - Don Ingber Megan Sperry Anish Vasan and many others nature.com/articles/s4385… "AI-enabled drug prediction and gene network analysis reveal therapeutic use of vorinostat for Rett Syndrome in preclinical models"

Congratulations to Samir Mitragotri for receiving the Founder’s Award from the Controlled Release Society, recognizing outstanding contributions to the field as well as exemplary leadership and impact on the scientific community. Wyss Institute @CRS

What a week! I am thrilled to have participated in the Controlled Release Society Annual Meeting in Philly. And incredibly honored to have received the CRS Presidential Poster Award! 🎉 A heartfelt thank you to CRIS contra el cáncer for funding this research at Harvard University Wyss Institute 💚 CRS Spanish Portuguese Local Chapter

Grantee the Wyss Institute (Wyss Institute for Biologically Inspired Engineering at Harvard) announced last month that it developed a new drug to treat coronaviruses using AI dynamic modeling! 👩‍🔬💊 #medicine #innovation #health wyss.harvard.edu/news/broad-spe…

Stem Cell Differentiation Method Induces Meiosis to Address Infertility A new approach triggers #meiosis, the cell division process responsible for producing egg and sperm, to aid future fertility treatments george church Wyss Institute #infertility #iPSCs hubs.li/Q03D8y8D0

Just published in ACS Central Science—our latest work using the Centrifuge Force Microscope to quantify immune-cell interactions. The new setup combines high-throughput force spectroscopy with multichannel fluorescence for single-cell studies. pubs.acs.org/doi/10.1021/ac…

We’re excited to share a new multi-year collaboration with Takeda, building on the success of our first engagement. Under the agreement, Nabla will receive double-digit millions in upfront and research payments and is eligible for success-based payments exceeding $1

Clinical researchers and bioengineers at SEAS and the Wyss Institute have developed slowly biodegradable, injectable biomaterial scaffold vaccines that could solve the problem of device infection in patients. bit.ly/4qGx8xl

A nonsurgical brain implant enabled through a cell–electronics hybrid for focal neuromodulation go.nature.com/3JuSNYH

Thank you Mass General Brigham Research for highlighting our work! Wyss Institute HST